417
Views
0
CrossRef citations to date
0
Altmetric
Meta-Analysis

Trans-femoral versus trans-carotid access for transcatheter aortic valve replacement: an updated systematic review and meta-analysis

, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & show all
Article: FSO930 | Received 06 Jun 2023, Accepted 27 Oct 2023, Published online: 08 Mar 2024

References

  • FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery. (FDA, Internet). https://www.fda.gov/news-events/press-announcements/fda-expands-indication-several-transcatheter-heart-valves-patients-low-risk-death-or-major
  • Mack MJ, Leon MB, Thourani VH et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N. Engl. J. Med. 380(18), 1695–1705 (2019).
  • Important Changes Published in the new 2020 ACC/AHA Valvular Heart Disease Guidelines. (Cedars-Sinai, Internet). https://www.cedars-sinai.org/blog/valvular-heart-disease-guidelines.html#:~:text=Finally%2C%20the%20other%20major%20changes,variety%20of%20settings%2C%20including%20postoperatively
  • Vahanian A, Beyersdorf F, Praz F et al. 2021 ESC/EACTS Guidelines for the management of valvular heart diseaseDeveloped by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 43(7), 531–632 (2021).
  • Hudziak D, Wojakowski W, Malinowski M et al. Comparison of the short-term safety and efficacy of transcarotid and transfemoral access routes for transcatheter aortic valve implantation. Kardiol. Pol. 79(1), 31–38 (2021).
  • Junquera L, Kalavrouziotis D, Côté M et al. Results of transcarotid compared with transfemoral transcatheter aortic valve replacement. J. Thorac. Cardiovasc. Surg. 163(1), 69–77 (2020).
  • Leclercq F, Choteau R, Cayla G et al. Transcarotid versus transfemoral access in patients undergoing transcatheter aortic valve replacement with complex aortofemoral anatomy. Catheter. Cardiovasc. Interv. 97(7), 1452–1459 (2021).
  • McGrath DP, Kawabori M, Wessler B, Chen FY, Zhan Y. A meta-analysis of transcarotid versus transfemoral transcatheter aortic valve replacement. Catheter. Cardiovasc. Interv. 98(January), 1–7 (2021).
  • Kirker E, Korngold E, Hodson RW et al. Transcarotid versus subclavian/axillary access for transcatheter aortic valve replacement with SAPIEN 3. Ann. Thorac. Surg. 110(6), 1892–1897 (2020).
  • Campelo-Parada F, Rodés-Cabau J, Dumont E et al. A novel transcarotid approach for implantation of balloon-expandable or self-expandable transcatheter aortic valves. Can. J. Cardiol. 32(12), 1575.e9–1575.e12 (2016).
  • Hutton B, Salanti G, Caldwell DM et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann. Intern. Med. 162, 777–784 (2015).
  • Villecourt A, Faroux L, Muneaux A et al. Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: a propensity-matched analysis. Arch. Cardiovasc. Dis. 113(3), 189–198 (2020).
  • Kappetein AP, Head SJ, Généreux P et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur. Heart J. 33(19), 2403–2418 (2012).
  • Wells G, Shea B, O'Connell D et al. Newcastle-Ottawa quality assessment scale case control studies, case control. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp ( last accessed 12 July 2017). 2–4 (2013).
  • Kirker EB, Hodson RW, Spinelli KJ, Korngold EC. The carotid artery as a preferred alternative access route for transcatheter aortic valve replacement. Ann. Thorac. Surg. 104(2), 621–629 (2017).
  • Olivier M-E, Di Cesare A, Poncet A et al. Transfemoral versus transcarotid access for transcatheter aortic valve replacement. JTCVS Tech. 15, 46–53 (2022).
  • Hoover NE, Ouranos HB, Memon S et al. Transcarotid Versus Transfemoral Transcatheter Aortic Valve Replacement (from a Propensity-Matched Comparison). Am. J. Cardiol. 185, 71–79 (2022).
  • Alperi A, McInerney A, Modine T et al. Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes. Interact. Cardiovasc. Thorac. Surg. 34(6), 982 (2022).
  • Jones BM, Kumar V, Chiu ST et al. Comparable outcomes for transcarotid and transfemoral transcatheter aortic valve replacement at a high volume US center. Semin. Thorac. Cardiovasc. Surg. 34(2), 467–474 (2022).
  • Marie B, David CH, Guimbretière G et al. Carotid versus femoral access for transcatheter aortic valve replacement: comparable results in the current era. Eur. J. Cardiothorac. Surg. 60(4), 874–879 (2021).
  • Beurtheret S, Karam N, Resseguier N et al. Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 74(22), 2728–2739 (2019).
  • Lu H, Monney P, Fournier S et al. Transcervical approach versus transfemoral approach for transcatheter aortic valve replacement. Int. J. Cardiol. 327, 58–62 (2021).
  • Paone G, Eng M, Kabbani LS et al. Transcatheter aortic valve replacement: comparing transfemoral, transcarotid, and transcaval access. Ann. Thorac. Surg. 106(4), 1105–1112 (2018).
  • Watanabe M, Takahashi S, Yamaoka H et al. Comparison of transcarotid vs. transfemoral transcatheter aortic valve implantation. Circ. J. 82(10), 2518–2522 (2018).
  • Fanaroff AC, Manandhar P, Holmes DR et al. Peripheral artery disease and transcatheter aortic valve replacement outcomes: a report from the society of thoracic surgeons/american college of cardiology transcatheter Therapy Registry. Circ. Cardiovasc. Interv. 10(10), e005456 (2017).
  • Guo R, Xie M, Yim WY et al. Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement. BMC Cardiovasc. Disord. 21(1), 1–13 (2021).
  • Würschinger F, Wittmann S, Goldfuß S et al. Complications after transcatheter aortic valve implantation using transfemoral and transapical approach in general anaesthesia. PLoS ONE 13(4), e0193558 (2018).
  • Auffret V, Lefevre T, Van Belle E et al. Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI. J. Am. Coll. Cardiol. 70(1), 42–55 (2017).
  • Holmes DR, Nishimura RA, Grover FL et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. Ann. Thorac. Surg. 101(2), 789–800 (2016).
  • Overtchouk P, Modine T. Alternate access for TAVI: stay clear of the chest. Interv. Cardiol. (London, England). 13(3), 145–150 (2018).
  • Vemulapalli S, Carroll JD, Mack MJ et al. Procedural Volume and Outcomes for Transcatheter Aortic-Valve Replacement. 380(26), 2541–2550 (2019).
  • Allen KB, Chhatriwalla AK, Cohen D et al. Transcarotid versus transapical and transaortic access for transcatheter aortic valve replacement. Ann. Thorac. Surg. 108(3), 715–722 (2019).
  • Lu H, Monney P, Hullin R et al. Transcarotid access versus transfemoral access for transcatheter aortic valve replacement: a systematic review and meta-analysis. Front. Cardiovasc. Med. 8, 687168 (2021).
  • Abraham B, Sous M, Sedhom R et al. Meta-analysis on transcarotid versus transfemoral and other alternate accesses for transcatheter aortic valve implantation. Am. J. Cardiol. 192, 196–205 (2023).
  • Généreux P, Webb JG, Svensson LG et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (placement of AoRTic TraNscathetER Valve) trial. J. Am. Coll. Cardiol. 60(12), 1043–1052 (2012).
  • Usman MS, Rawasia WF, Siddiqi TJ, Mujeeb FA, Nadeem S, Alkhouli M. Meta-analysis evaluating the safety and efficacy of transcarotid transcatheter aortic valve implantation. Am. J. Cardiol. 124(12), 1940–1946 (2019).
  • Overtchouk P, Alqdeimat I, Coisne A, Fattouch K, Modine T. Transcarotid approach for TAVI: an optimal alternative to the transfemoral gold standard. Ann. Cardiothorac. Surg. 6(5), 555–557 (2017).
  • Mylotte D, Sudre A, Teiger E et al. Transcarotid transcatheter aortic valve replacement: feasibility and safety. JACC. Cardiovasc. Interv. 9(5), 472–480 (2016).
  • Folliguet T, Laurent N, Bertram M et al. Transcarotid transcatheter aortic valve implantation: multicentre experience in France. Eur. J. cardio-thoracic Surg. 53(1), 157–161 (2018).
  • Tsai R, Chen IM, Chen PL, Leu HB, Chen YH, Chang HH. Increase carotid flow by double sheath connection technique to reduce cerebral ischemia for transcatheter aortic valve implantation through transcarotid approach. Ann. Thorac. Cardiovasc. Surg. 24(3), 161–164 (2018).
  • Kahlert P, Al-Rashid F, Döttger P et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation 126(10), 1245–1255 (2012).
  • Despotis G, Avidan M, Eby C. Prediction and management of bleeding in cardiac surgery. J. Thromb. Haemost. 7(Suppl. 1), 111–117 (2009).
  • Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364(23), 2187–2198 (2011).